Aurobindo Pharma Limited

NSE:AUROPHARMA India Drug Manufacturers - Specialty & Generic
Market Cap
$8.62 Billion
₹746.91 Billion INR
Market Cap Rank
#3188 Global
#87 in India
Share Price
₹1286.00
Change (1 day)
-0.81%
52-Week Range
₹1022.20 - ₹1311.90
All Time High
₹1568.05
About

Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system,… Read more

Aurobindo Pharma Limited (AUROPHARMA) - Total Liabilities

Latest total liabilities as of September 2025: ₹175.12 Billion INR

Based on the latest financial reports, Aurobindo Pharma Limited (AUROPHARMA) has total liabilities worth ₹175.12 Billion INR as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Aurobindo Pharma Limited - Total Liabilities Trend (2004–2025)

This chart illustrates how Aurobindo Pharma Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Aurobindo Pharma Limited Competitors by Total Liabilities

The table below lists competitors of Aurobindo Pharma Limited ranked by their total liabilities.

Company Country Total Liabilities
Broadex Technologies Co Ltd
SHE:300548
China CN¥1.14 Billion
Hua Hong Semiconductor Limited
PINK:HHUSF
USA $3.48 Billion
PriceSmart Inc
NASDAQ:PSMT
USA $1.09 Billion
Mobile World Investment Corp
VN:MWG
Vietnam ₫50.78 Trillion
Ampol Limited
F:CLZ
Germany €10.26 Billion
MDU Resources Group Inc
NYSE:MDU
USA $-2.72 Billion
Western Superconducting Tech Co Ltd
SHG:688122
China CN¥7.07 Billion

Liability Composition Analysis (2004–2025)

This chart breaks down Aurobindo Pharma Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.85 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.57 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.50 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.33 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Aurobindo Pharma Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Aurobindo Pharma Limited (2004–2025)

The table below shows the annual total liabilities of Aurobindo Pharma Limited from 2004 to 2025.

Year Total Liabilities Change
2025-03-31 ₹171.38 Billion +12.60%
2024-03-31 ₹152.21 Billion +16.74%
2023-03-31 ₹130.38 Billion +39.48%
2022-03-31 ₹93.48 Billion -21.61%
2021-03-31 ₹119.25 Billion -1.47%
2020-03-31 ₹121.03 Billion -3.65%
2019-03-31 ₹125.62 Billion +33.37%
2018-03-31 ₹94.19 Billion +36.99%
2017-03-31 ₹68.75 Billion -24.47%
2016-03-31 ₹91.02 Billion +17.71%
2015-03-31 ₹77.33 Billion +35.33%
2014-03-31 ₹57.14 Billion +22.72%
2013-03-31 ₹46.56 Billion +19.76%
2012-03-31 ₹38.88 Billion +13.57%
2011-03-31 ₹34.23 Billion +15.73%
2010-03-31 ₹29.58 Billion -0.81%
2009-03-31 ₹29.82 Billion +18.94%
2008-03-31 ₹25.07 Billion -4.19%
2007-03-31 ₹26.17 Billion +39.78%
2006-03-31 ₹18.72 Billion +32.28%
2005-03-31 ₹14.15 Billion +24.05%
2004-03-31 ₹11.41 Billion --